Fund Holdings — Deep Track Capital, LP

Total Portfolio Value:
$4.85B
Total Bought:
$1.42B
Total Sold:
$803.53M
Net Transaction:
+$620.35M
Securities
▲▼
SharesValue
Q4 2025
▲▼
Q1 2026
▲▼
Change
▲▼
Q4 2025
▲▼
Q1 2026
▲▼
Weight (%)
▲▼
Change
▲▼
Guardant Health, Inc.(GH)2,800,0003,338,241+538,241$285.99M$308.35M6.36%+$22.36M
Immunovant, Inc.(IMVT)11,526,97111,526,9710$293.02M$286.33M5.91%-$6.69M
Tarsus Pharmaceuticals, Inc.(TARS)3,004,0343,600,000+595,966$245.97M$252.54M5.21%+$6.57M
Vaxcyte, Inc.(PCVX)4,000,0004,300,000+300,000$184.56M$249.87M5.16%+$65.31M
Structure Therapeutics IncADS4,111,7824,279,848+168,066$285.97M$206.29M4.26%-$79.69M
Axsome Therapeutics, Inc.(AXSM)1,150,0001,100,000-50,000$210.04M$185.92M3.84%-$24.11M
Apellis Pharmaceuticals Inc
COM
7,750,0004,532,374-3,217,626$194.68M$182.34M3.76%-$12.34M
Ocular Therapeutix, Inc.(OCUL)8,070,41419,686,282+11,615,868$97.97M$166.74M3.44%+$68.77M
Vera Therapeutics, Inc.CL A(VERA)2,821,1354,106,067+1,284,932$142.86M$165.19M3.41%+$22.32M
Alumis Inc06,772,595+6,772,595$0$149.20M3.08%+$149.20M
Ionis Pharmaceuticals, Inc.(IONS)1,700,0001,950,000+250,000$134.49M$146.43M3.02%+$11.94M
Nuvalent Inc01,376,324+1,376,324$0$141.00M2.91%+$141.00M
Alkermes plcSHS(ALKS)2,000,0003,590,323+1,590,323$55.96M$126.95M2.62%+$70.99M
Centessa Pharmaceuticals PlcADS2,000,0003,158,041+1,158,041$50.02M$125.44M2.59%+$75.42M
MoonLake ImmunotherapeuticsCL A(MLTX)4,610,0716,408,863+1,798,792$60.76M$119.46M2.47%+$58.70M
Maze Therapeutics, Inc.(MAZE)4,246,4403,477,562-768,878$175.93M$103.81M2.14%-$72.12M
Oruka Therapeutics, Inc.(ORKA)2,161,5102,034,203-127,307$65.52M$99.78M2.06%+$34.26M
Nurix Therapeutics, Inc.(NRIX)7,036,4556,345,244-691,211$133.48M$98.35M2.03%-$35.13M
Genmab A/SADS(GMAB)03,663,250+3,663,250$0$98.28M2.03%+$98.28M
Cytokinetics, Incorporated(CYTK)3,336,9981,374,320-1,962,678$212.03M$90.58M1.87%-$121.45M
GRAIL, Inc.(GRAL)1,022,7971,722,797+700,000$87.54M$89.03M1.84%+$1.49M
LB Pharmaceuticals Inc(LBRX)3,352,8043,352,8040$74.63M$82.68M1.71%+$8.05M
MBX Biosciences, Inc.(MBX)3,249,7902,757,569-492,221$102.50M$82.31M1.70%-$20.18M
Bicara Therapeutics Inc2,614,0044,062,500+1,448,496$43.99M$80.80M1.67%+$36.81M
COMPASS Pathways plcADS(CMPS)7,334,32312,161,496+4,827,173$50.61M$67.25M1.39%+$16.65M
BioMarin Pharmaceutical Inc.(BMRN)2,300,0001,150,000-1,150,000$136.69M$64.96M1.34%-$71.73M
BridgeBio Pharma, Inc.(BBIO)810,142841,445+31,303$61.97M$62.49M1.29%+$517.9K
Immunocore Holdings plcADS(IMCR)2,003,9781,931,884-72,094$69.56M$58.25M1.20%-$11.31M
Tango Therapeutics, Inc.(TNGX)2,454,5622,750,000+295,438$21.75M$57.53M1.19%+$35.78M
Definium Therapeutics, Inc.(DFTX)03,000,000+3,000,000$0$56.70M1.17%+$56.70M
Terns Pharmaceuticals Inc769,0481,073,877+304,829$31.07M$56.61M1.17%+$25.55M
Geron Corporation(GERN)32,511,27131,720,278-790,993$42.91M$47.26M0.98%+$4.35M
ANI Pharmaceuticals, Inc.(ANIP)477,684600,000+122,316$37.71M$46.14M0.95%+$8.43M
CorMedix Inc.(CRMD)5,274,0766,274,076+1,000,000$61.34M$42.60M0.88%-$18.74M
Ataibeckley Inc012,000,000+12,000,000$0$42.48M0.88%+$42.48M
Celldex Therapeutics, Inc.(CLDX)1,900,7381,283,979-616,759$51.62M$40.73M0.84%-$10.90M
Cogent Biosciences, Inc.(COGT)453,1021,000,000+546,898$16.09M$38.49M0.79%+$22.40M
Corvus Pharmaceuticals, Inc.(CRVS)02,491,539+2,491,539$0$36.45M0.75%+$36.45M
Dyne Therapeutics, Inc.(DYN)2,650,0002,000,000-650,000$51.83M$36.26M0.75%-$15.57M
Soleno Therapeutics Inc1,000,0001,078,710+78,710$46.30M$36.12M0.75%-$10.18M
Aclaris Therapeutics, Inc.(ACRS)09,345,000+9,345,000$0$35.04M0.72%+$35.04M
Veradermics, Incorporated(MANE)0500,000+500,000$0$31.57M0.65%+$31.57M
Verastem, Inc.(VSTM)5,740,8505,740,8500$44.32M$30.43M0.63%-$13.89M
Engene Holdings Inc
COM
4,377,5724,377,5720$39.53M$29.81M0.62%-$9.72M
Viridian Therapeutics, Inc.(VRDN)2,524,8331,393,944-1,130,889$78.57M$27.27M0.56%-$51.31M
X4 Pharmaceuticals, Inc.(XFOR)5,013,6616,339,535+1,325,874$20.05M$26.18M0.54%+$6.13M
Solid Biosciences Inc03,565,062+3,565,062$0$25.67M0.53%+$25.67M
Enanta Pharmaceuticals, Inc.(ENTA)1,956,8671,956,8670$30.86M$24.72M0.51%-$6.14M
Apogee Therapeutics Inc0285,000+285,000$0$23.99M0.49%+$23.99M
Kura Oncology, Inc.(KURA)02,643,542+2,643,542$0$21.49M0.44%+$21.49M
Century Therapeutics, Inc.(IPSC)09,487,745+9,487,745$0$21.44M0.44%+$21.44M
Beam Therapeutics Inc.(BEAM)0820,765+820,765$0$19.56M0.40%+$19.56M
Context Therapeutics Inc.(CNTX)7,419,3557,419,3550$10.91M$19.44M0.40%+$8.53M
Personalis, Inc.(PSNL)03,000,000+3,000,000$0$19.11M0.39%+$19.11M
Janux Therapeutics, Inc.(JANX)89,5891,187,290+1,097,701$1.24M$16.50M0.34%+$15.27M
ProMIS Neurosciences, Inc.(PMN)0835,655+835,655$0$10.61M0.22%+$10.61M
Crescent Biopharma, Inc.(CBIO)453,686453,6860$5.38M$8.33M0.17%+$2.95M
Inventiva S.A.ADS(IVA)490,0001,222,453+732,453$2.28M$6.78M0.14%+$4.51M
Larimar Therapeutics, Inc.(LRMR)01,500,000+1,500,000$0$6.75M0.14%+$6.75M
Cybin D/B/A Helus Pharma(HELP)1,854,2551,313,137-541,118$15.17M$6.30M0.13%-$8.86M
Billiontoone IncCL A50,00050,0000$4.09M$3.95M0.08%-$145.0K
Aligos Therapeutics, Inc.(ALGS)444,110444,1100$4.14M$3.30M0.07%-$839.4K
Adlai Nortye Group Ltd.ADS(ANL)34,8520-34,852$49.5K$0—-$49.5K
Atai Beckley NvSHS4,677,2890-4,677,289$19.13M$0—-$19.13M
Dynavax Technologies Corp15,726,3490-15,726,349$241.87M$0—-$241.87M
Mind Medicine Mindmed Inc1,676,5400-1,676,540$22.45M$0—-$22.45M
Monopar Therapeutics Inc.(MNPR)95,4080-95,408$6.23M$0—-$6.23M
Rapt Therapeutics Inc110,4480-110,448$3.74M$0—-$3.74M
Xenon Pharmaceuticals Inc.(XENE)366,4350-366,435$16.42M$0—-$16.42M
Page 1 of 1
Deep Track Capital, LP — 13F Holdings — Q1 2026 | TickerTrail